ESR1 and cancer: The growth of approximately 70% of breast cancers depends on estrogen (i.e., 17b-estradiol (E2)) and estrogen receptor (ER) signaling, with estrogen receptor α (ERα) playing a more prominent role in cancer progression than estrogen receptor β (ERβ) [2].